CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 309 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04520191
NCT04520191N/ACompleted

Home-based Kidney Care in Native Americans of New Mexico (HBKC) - COVID-19 Related Disruption in Health and Health Care

University of New Mexico·observational·Posted Aug 20, 2020·Updated Mar 4, 2025

In Brief

An observational study for CKD. Completed, enrolled 309 participants across 1 site.

Detailed Summary

Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) OR COVID-19 related Addition: The aim of this addition activity is to track the impact of the COVID-19 epidemic on participants with diabetes and chronic kidney disease (CKD). Investigators have modified the original HBKC Study protocol to expand data currently collected from study participants to include data in the following domains linked to the COVID-19 epidemic: symptoms of COVID-19 disease, access to healthcare, and impact on health related behaviors (such as medication adherence, physical activity, dietary behaviors, smoking, and alcohol use).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCKD
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedAug 20, 2020
Enrollment StartJan 4, 2021
Primary CompletionAug 1, 2024
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 5.9 years ago